CHEMED CORPORATION Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
CHEMED CORPORATION (CHE) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 0.40% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-02-27
- CHEMED CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was 0.40%, a 33.33% increase from fiscal 2024.
- CHEMED CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2024 was 0.30%, a 0.00% change from fiscal 2023.
- CHEMED CORPORATION effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2023 was 0.30%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month |
|---|---|
| 2025-12-31 | 0.40% 10-K · filed 2026-02-27 |
| 2024-12-31 | 0.30% 10-K · filed 2026-02-27 |
| 2023-12-31 | 0.30% 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Option Care Health, Inc. (OPCH) | United States | $3.602B | 20.52 |
| Aveanna Healthcare Holdings, Inc. (AVAH) | United States | $2.703B | 7.22 |
| Addus HomeCare Corp (ADUS) | United States | $2.129B | 17.80 |
| BrightSpring Health Services, Inc. (BTSG) | United States | $11.078B | 37.65 |
| AdaptHealth Corp. (AHCO) | United States | $0.759B | -6.22 |